The Decentralized Clinical trails Goal is to provide a hybrid, flexible system that can promote high patient engagement and patient-centric study. Check out this blog to know, Why decentralized Clinical trials are the way of the future.

1. THE FUTURE OF CLINICAL TRIALS
DECENTRALISATION

2. WHAT MAKES
DECENTRALISATION THE
FUTURE OF CLINICAL TRIALS?
With the emergence of COVID-19, Decentralisation of Clinical Trials
became necessary to comply with social distancing requirements
while carrying out clinical research. Over the past few years, the
clinical trial landscape has shifted its focus to patient-centric
practices to promote patient engagement. But now as the pandemic
is long gone, it is time to reflect on how DCT studies are genuinely
addressing long-standing issues in research and development for
sponsors, study teams, and of course, the patients!
CROs to take the first step toward the future of clinical trials
ClinionAI

3. WHAT IS A
DECENTRALISED
CLINICAL TRIAL?
Decentralised clinical trials involve a combination of
innovative technologies with a patient-centric study
design to communicate with study participants and
collect data for conducting clinical studies using a
hybrid approach
The primary goal of DCT is to
provide a hybrid, flexible
system that can promote high
patient engagemen
ClinionAI

4. Traditional trials vs Decentralised trials
Site-centred advertising
targeting local participants
In-person consent, via
physical signature
In-person physical tests
In-person recruitment
On-site treatment and check
up where patients have to visit
the site
Low – due to scheduled in-person
patient visits
Delayed – Requires final in-
person visits
Digital advertising, allowing CROs
to reach a diverse patient
population.
E-consent (digital consent
signature) form patients located far
away from the site
Tele-consultation and home visits
by medical personnel and nursing
staff
Virtual recruitment
Home healthcare and
teleconsultation. Remote
monitoring by devices and self-
care platforms

5. WHY DECENTRALISED
CLINICAL TRIALS ARE THE
WAY OF THE FUTURE?
With the growing need for accelerated drug development, traditional site-
centric clinical trial models have evolved to handle consumer requirements
during unforeseen events. According to recent data published by the
Globaldata Pharma Intelligence Center, decentralised or remote clinical
trials have successfully brought research closer to the patients, with an
overall increase of 1.3% of all trials in 2011 to 2.5% in 2020.
Allows for a greater
geographical reach, which is
important for enrolling a
diverse group of participants.
Eliminates the need for
travel, which can be a barrier
to participation.

6. CONTACT
CORPORATE
To get started with Clinion integrated
DCT platform, reach out to our experts!
sales@clinion.com
EMAIL ADDRESS
+91 733 738 2327
PHONE NUMBER WEBSITE
https://www.clinion.com/

7. THANK YOU!!
REVOLUTIONISE YOUR CLINICAL TRIAL EXPERIENCE WITH AI-ENABLED AUTOMATION